期刊文献+

伊布利特转复老年心房颤动出现长R-R间歇 被引量:1

Long R-R interval occurring in an elderly patient receining ibutilide for cardioversion of atrial fibrillation
原文传递
导出
摘要 1例77岁男性患者,给予伊布利特1mg溶于0.9%氯化钠注射液50mL中缓慢静脉推注以转复心房颤动。给药16min后转为窦性心律,但转复过程中患者出现十余次窦性停搏,最长R-R间歇4.872s。患者无头晕、头痛、胸痛、胸闷等症状。转复成功后,患者继续服用普罗帕酮、美托洛尔、华法林等药物,无任何不适。 A 77-year-old male patient received a slowly IV push of ibutilide 1 mg dissolved in 50 mL of 0.9% sodium chloride for his atrial fibrillation(AF) conversion. After sixteen minutes,AF was converted to sinus rhythm. But he experienced 10 episodes of sinus arrest with the longest R-R interval of 4.872 seconds. The patient did not have dizziness,headache,chest pain,chest discomfort. After AF was successfully converted,the patient continued to take propafenone,metoprol,warfarin without any discomforts.
出处 《药物不良反应杂志》 2010年第4期280-281,共2页 Adverse Drug Reactions Journal
关键词 伊布利特 转复 心房颤动 不良反应 窦性停搏 ibutilide cardioversion atrial fibrillation adverse reactions sinus arrest
  • 相关文献

参考文献5

  • 1Kowey PR, Vanderlugt JT, Luderer JR. Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter [J]. Am J Cardiol, 1996, 78(8A) : 46-52.
  • 2Fuster V, Rydrn LE, Cannom DS, et al. ACC/AHA/ ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) : developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation, 2006, 114 ( 7 ) : e257-354.
  • 3Fragakis N, Papadopoulos N, Papanastasion S, et al. Efficacy and safety of ibtilide for cardivoversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone [ J ]. Pacing Clin Electrophysiol, 2005, 28 (9) :954-961.
  • 4Hongo RH, Themistoclakis S, Raviele A, et al. Use of ibtilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents [ J ]. J Am Coll Cardiol, 2004, 44(4) : 864-868.
  • 5任政文,周颖,崔一民.伊布利特引起的心律失常及防治[J].药物不良反应杂志,2010,12(3):188-193. 被引量:2

二级参考文献21

  • 1黄冬,李京波,魏盟.伊布利特抗心律失常作用的电生理学基础及其临床意义[J].中国新药与临床杂志,2005,24(11):910-912. 被引量:8
  • 2田蕾,蒋娟娟,黄一玲,华潞,况扶华,李一石.伊布利特注射液的中国人人体药动学[J].中国新药与临床杂志,2006,25(7):531-534. 被引量:2
  • 3周立君,刘晶,李为民.伊布利特致尖端扭转性室性心动过速一例[J].中华心律失常学杂志,2006,10(4):307-308. 被引量:4
  • 4Greene HL, Roden DM, Katz RJ, et al. The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-II [J]. J Am Coll Cardiol, 1992(5), 19:894-898.
  • 5Gowda RM, Khan IA, Punukollu G, et al. Female preponderance in ibutilide-induced torsade de pointes [ J ]. Int J Cardiol, 2004, 95(2-3) : 219- 222.
  • 6Abi-Mansour P, Carberry PA, McCowan R J, et al. Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation. Study Investigators[J]. Am Heart J, 1998, 136(4 Pt 1) :632-642.
  • 7VanderLugt JT, Mattioni T, Denker S, et al. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery [ J ]. 1999, 100 ( 4 ) : 369-375.
  • 8Oral H, Souza JJ, Michaud GF, et al. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment[J]. N Eng J Med. 1999, 340(24) : 1849-1854.
  • 9Santini M, Pignalberi C, Ricci R, et al. Effectiveness of ibutilide in cardioversion of persistent atrial fibrillation in patients with dual chamber stimulation [ J ]. J Int Card Electrophysiol. 2003, 9(1 ) : 15-20.
  • 10Hongo RH, Themistoclakis S, Raviele A, et al. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents[ J]. J Am Coll Cardiol. 2004, 44(4) : 864-868.

共引文献1

同被引文献19

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部